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abstract
HIV and opportunistic infections remain a big problem especially in developing country. Pneumocystis jiroveci pneumonia is a 
prevalent infection in HIV infected patient with high mortality rate. Diagnosis of Pneumocystis jiroveci pneumonia is mainly based 
on clinical evidence. Microbiological diagnosis is quite challenging since this microorganism cannot be cultured and is mainly based 
on microscopic examination. Microscopic examination with special staining is still a gold standard diagnosis for P. jiroveci infection.
The objectives of this study was to describe CD4 lymphocyte profile and establish microbiological diagnosis with recent molecular 
method in PJP suspected HIV positive patients. Fiberoptic bronchoscopy of HIV infected patients with lower respiratory tract infection 
in Dr. Soetomo general hospital Surabaya were performed to collect bronchoalveolar lavage specimens from December 2016 to April 
2017 for identification of Pneumocystis jiroveci using real time PCR assay. Positive samples were then evaluated for microscopic 
examination with Gommori Methenamine Silver staining for comparison. Patient’s CD4 lymphocyte count were gathered prior of 
admission. CD4 lymphocyte count from this study were very low with 61% of the patients were below 50 cells/ µL. There were five of 
total thirteen patients (38,5%) with positive real time PCR assay (MSG gene) and one patient was also positive with GMS staining 
showing characteristic cysts shape with dark centered area of P. jiroveci. Patient with positive microscopic examination showed no 
history of prophylactic therapy. Low CD4 lymphocyte count remains a strong risk factor of P. jiroveci pneumonia in HIV/AIDS patients. 
Real time PCR assay shows high value in detection of P. jiroveci regarding patient’s prophylactic status.
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abstrak
HIV dan infeksi oportunistik masih merupakan masalah yang banyak ditemui terutama pada negara berkembang. Pneumocystis 
jiroveci pneumonia merupakan infeksi yang banyak ditemui pada pasien HIV dan memiliki angka kematian yang tinggi. Diagnosis 
Pneumocystis jiroveci pneumonia terutama berdasarkan gejala klinis. Diagnosis mikrobiologi merupakan suatu tantangan tersendiri 
karena mikroorganisme ini tidak dapat dikultur dan diagnosis utamanya bergantung dari pemeriksaan mikroskopis. Pemeriksaan 
baku emas untuk diagnosis infeksi P. jiroveci adalah dengan pemeriksaan mikroskopis dengan pewarnaan khusus. Tujuan dari studi 
ini adalah untuk menggambarkan profil jumlah hitung limfosit CD4 pada pasien HIV dan menegakkan diagnosis mikrobiologis PJP 
dengan metode molekular terbaru pada pasien yang dicurigai infeksi PJP. Pemeriksaan bronkoskopi fiber optik dilakukan pada pasien 
HIV dengan infeksi saluran nafas bawah di RSUD Dr. Soetomo untuk mengumpulkan spesimen broncoalveolar lavage, spesimen klinis 
dikumpulkan dalam rentang waktu Desember 2016 hingga April 2017 untuk dilakukan identifikasi P. jiroveci dengan pemeriksaan real 
time PCR. Sampel dengan hasil positif kemudian dilakukan pemeriksaan mikroskopis dengan pewarnaan Gommori Methenamine Silver 
sebagai perbandingan. Pemeriksaan hitung jumlah limfosit CD4 dilakukan pada awal pasien masuk rumah sakit. Hitung jumlah yang 
didapatkan pada studi ini didapatkan hasil sangat rendah, yaitu 61% didapatkan hitung jumlah limfosit CD4 di bawah 50 sel / µL. Lima 
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introduction
Human Immunodeficiency Virus (HIV) is a virus that 
attack immune cells and weaken the immune system. 
Cummulative data reported from Indonesia Ministry of 
Health showed that there were 191,073 persons with HIV 
infection and 77,940 persons with AIDs.1 By 2014, there 
were estimated 37,600 persons with new HIV infection in 
UsA. Opportunistic infection rarely occur at early stage of 
HIV infection, the use of antiretroviral therapy can reduce 
the viral load in the patient and maintain immune system.2 
In Indonesia, antiretroviral therapy coverage is quite low 
(11.67%) compared with high income countries where the 
coverage is expected to be more than 45%.3 several studies 
shows that at least 33.3% HIV patients with antiretroviral 
therapy will experience at least one time opportunistic 
infection during the study period and the general 
prevalence of opportunistic infection in HIV persons 
is 42.8% including recurrent infection.2,4 Pneumonia is 
one of the most prevalent opportunistic infection in HIV 
patients, it covers around 22.1% of the total opportunistic 
infection.4 The frequency of opportunistic infection may 
vary on each country because differences in genetic factor, 
environmental factor, and the people social background 
such as discrimination and stigmata which remain a 
potential difficulty in diagnosis and treating infection.5
Pneumocystic jiroveci is an opportunistic pathogen 
that often occur in immunocompromised persons with 
high mortality rate and strongly related with HIV/AIDs 
condition.6 The chance of patient with HIV/AIDs will 
experience Pneumocystis jiroveci Pneumonia (PJP) was 
75% in their course of the disease.7 Multicenter study in 
Korea showed that prevalence of PJP in HIV/AIDs patient 
were 11.1%. PJP is the third most prevalent opportunistic 
infection in HIV patient after Candida infection and 
tuberculosis infection.8
Chemoprophylaxis in PJP suspected HIV/AIDs patients 
is directed to prevent PJP infection but even with routine 
prophylaxis, the death of PJP related in HIV/AIDs patient 
is around 12% to 33% depending on resources and facility 
of the hospital where the patient admitted.9
material and method
clinical specimens
Fiberoptic bronchoscopy in order to collect 
bronchoalveolar lavage is an invasive and expensive 
procedure especially for patient with respiratory problem. 
They were performed by pulmonologist and to minimize 
the risk factor for the development of adverse effects, the 
patients should have had minimal prerequisite lung function 
status, arterial blood gas recent data, platelet count and 
prothrombin time. A total of 13 bronchoalveolar lavage 
specimens from HIV/AIDs patients with pneumonia 
were collected in 5 month period from December 2016 
until April 2017. The patient’s blood was taken and sent 
to the Clinical Pathology laboratory for CD4 lymphocyte 
count using flowcytometry method. This research has been 
approved by the hospital ethic committee no. 401/Panke.
KKE/VI/ 2017.
specimens processing
BAL specimens were centrifuged at 3000g for 15 
minutes. supernatant were removed. After the removal of 
supernatant, 1 ml sedimentation were resuspended with 
mixed pipetting, aliquote of the sediment were smear on an 
object glass for GMs staining and the rest of the sediment 
were transferred in a microcentrifuge tube and kept in -80°C 
freezer until DNA extraction were performed.
GMs staining
The BAL smears were fixed in alcohol 95% overnight 
and then ready to be stained according to the staining 
procedure.
Real Time pcR Assay
Before the PCR assay, DNA extraction were done 
with QIAamp DNA mini kit (Qiagen) according to the 
manufacturer’s procedure. The real time PCR assay 
were performed by Roche molecular system using Roche 
light cycler 2.0. The primers used were specific for 
Major surface Glycoprotein (MsG) gene. The sequence 
of the primers were as follows: forward primer 5’-
CAAAAATAACAYTsACATCAACRAGG-3’, reverse 
dari total 13 pasien didapatkan hasil positif pemeriksaan real time PCR (gen MSG) dan salah seorang diantaranya didapatkan hasil 
positif dari pemeriksaan mikroskopis yaitu ditemukannya bentukan karakteristik kista dengan area kehitaman pada bagian tengah dengan 
pewarnaan GMS. Pasien dengan hasil positif pemeriksaan mikroskopis tidak memiliki riwayat terapi profilaksis sebelumnya. Hitung 
jumlah limfosit CD4 merupakan faktor risiko yang kuat terhadap terjadinya P. jiroveci pneumonia pada pasien HIV/AIDS. Pemeriksaan 
real time PCR menunjukkan nilai yang tinggi dalam mendeteksi P. jiroveci tanpa memandang status profilaksis pasien.
Kata kunci: HIV/AIDS, Pneumocystis jiroveci, pneumonia, hitung jumlah limfosit CD4 rendah, RSUD Dr Soetomo Surabaya
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primer 5’-AAATCATGAACGAAATAACCATTGC–3’, 
and probe 5’– TGCAAACCAACCAGTGCACGACAGG 
– 3’. Master mix was prepared, aliquote of the master mix 
was pipette 15 µl and added by 5 µl extracted sample. The 
reaction was consist of one cycle of denaturation in 95°C 
for 10 minutes, continue with 45 cycles of annealing at 
95°C for 10 seconds and extention at 58°C for 1 minutes. 
All reactions were run simultaneously with positive and 
negative controls.
prevention of contamination
Prevention of contamination including the use of 
aerosol barrier pipette tips, the use of separate areas of 
the laboratory for master mix preparation and specimens 
DNA extraction.
result and discussion
Of the 13 specimens tested, 61% of the blood specimens 
showed very low CD4 lymphocyte count below 50 cells/
µL (Figure 1). The mean CD4 lymphocyte value was 82,69 
cells / µL (Table 1). This result is similar to a multicenter 
study in Korea which stated that 65% patient with PJP 
showed very low count below 50 cells / µL.8 Low CD4 
lymphocyte count is a risk factor for PJP infection, other 
risk factor of PJP are P. jiroveci past infection, oral 
candidiasis, recurrent bacterial pneumonia, loss of body 
weight, high HIV viral load10 and genotipic relationship 
with mannose-binding lectin.11 
Real time PCR assay were performed on all BAL 
specimens and 5 (38.5%) were positives (Table 2). One 
specimen was positive with PCR assay and microscopy 
examination with GMs staining (Figure 2). BAL is the best 
specimen for detection of P. jiroveci cyst because lavage 
in each lung segment can overcome more than 1 million 
alveoli, it is estimated that up to 3% of the lung tissue can 
be sampled.12 Real time PCR assay has sensitivity up to 
96% in detecting 70 cases of PJP with negative microscopy 
examination and 94% in detecting 71 cases of PJP with 
positive microscopy examination, this assay rarely resulting 
false positive.13 Positive results must be interpreted 
carefully since this assay has high sensitivity value, a 
positive result without evident clinical symptoms and 
negative microscopy examination might be colonization 
or asymptomatic carrier of this microorganism.11 Negative 
PCR assay can be concluded true negative.14 PJP-HIV/
AIDs patients with negative microscopy examination often 
are colonized with P. jiroveci.15 This might be true in this 
research since among the positives PCR result, there is only 
1 positive microscopy examination.
Real time PCR is a semi quantitative method. The 
result of this assay can be concluded negative when there 
are no DNA detected and no increase of cycle threshold 
(CT) value, on the other hand positive when the targeted 
DNA is detected and there is an increase of cycle threshold 
value below 45 cycles. The less cycle the increasing of 
CT indicated the more targeted DNA load in the sample.16 
Cycle threshold value positively correlated with the 
microorganism density in the sample.17 A cut off CT value 
of 32 cycle can be applied in differentiating colonization 
to P. jiroveci infection with sensitivity 72% and specificity 
75%.17
Table 2. Real time PCR assay of BAL specimens from HIV/
AIDs patients with pneumonia in Dr. soetomo 
Hospital, period December 2016 – April 2017 
Real Time pcR pJp n %
Positive 5 38.5
Negative 8 61.5
Total 13 100
Table 3.  Association of CD4 lymphocyte count with real 
time PCR P. jiroveci from HIV/AIDs patients with 
pneumonia in Dr. soetomo Hospital, period December 
2016 – April 2017 
Real Time pcR p. jiroveci
Total
positive negative
cD4 < 200  5  0  5
cD4 > 200  0  8  8
Total  5  8  13
CD4 lymphocyte count and P. jiroveci as an agent of 
pneumonia show significant relationship with p value 0.002. 
Opportunistic infection with low CD4 count below 200 cells 
/ µL was dominated with P. jiroveci infection compare to 
other causes such as Cryptococcus and toxoplasmosis.18,19 It 
is clinically evident that CD4 lymphocyte count can be use 
Table 1.  Characteristic of CD4 lymphocyte count in HIV/AIDs 
patients with pneumonia in Dr. soetomo Hospital 
surabaya from December 2016 to April 2017 
n  Mean Median
CD4 lymphocyte count  13  82.69 cells/ µL  15 cells/µL
 
 
Figure 1. Distribution of CD4 lymphocyte count in HIV/AIDS patients with pneumonia from December 2016 to April 2017 
 
Real time PCR assay were performed on all BAL specimens and 5 (38,5%) were positives 
(Table 2). One specimen was positive with PCR assay and microscopy examination with GMS 
staining (Figure 2). BAL is the best specimen for detection of P. jiroveci cyst because lavage in each 
lung segment can overcome more than 1 million alveoli, it is estimated that up to 3% of the lung 
tissue can be sampled.12 Real time PCR assay has sensitivity up to 96% in detecting 70 cases of PJP 
with negative microscopy examination and 94% in detecting 71 cases of PJP with positive 
microscopy examination, this assay rarely resulting false positive.13 Positive results must be 
interpreted carefully since this assay has high sensitivity value, a positive result without evident 
clinical symptoms and negative microscopy examination might be colonization or asymptomatic 
carrier of this microorganism.11 Negative PCR assay can be concluded true negative.14 PJP-
HIV/AIDS patients with negative microscopy examination often are colonized with P. jiroveci.15 This 
might be true in this research since among the positives PCR result, there is only 1 positive 
microscopy examination. 
Real time PCR is a semi quantitative method. The result of this assay can be concluded 
negative when there are no DNA detected and no increase of cycle threshold (CT) value, on the other 
hand positive when the targeted DNA is detected and there is an increase of  cycle threshold value 
below 45 cycles. The less cycle the increasing of CT indicated the more targeted DNA load in the 
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figure 1. Distribution of CD4 lymphocyte count in HIV/AIDs 
patients with pneumonia from December 2016 to 
April 2017
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as a biomarker for immunodeficient condition and related 
to opportunistic infection.19 Yanagisawa and Nojima also 
stated that PJP prevalency in HIV/AIDs patient is 50% 
higher in CD4 lymphocyte count below 200 cells/ µL.11
Trimethoprim-sulfamethoxazole is one of few 
prophylactic therapy used for PJP, prophylactic is usually 
started when HIV/AIDs patient with low CD4 lymphocyte 
count is admitted in the hospital, especially when this 
patient come with clinical symptom and radiologic 
supporting pneumonia. Of all 13 patients, more than 50% 
already administered trimethoprim-sulfamethoxazole 
for prophylactic therapy, the fiber optic bronchoscopy 
procedure was performed after more than 2 days of 
prophylactic therapy. Among the 7 patients with therapy, 
positive PCR result was found in 4 patients (Table 4). 
One positive PCR result was found in non prophylactic 
patient.
figure 2.  GMs staining of BAL smear from positive real time 
PCR assay showing characteristic cyst shape with 
dark centered area
The diagnosis of PJP relies on microscopy detection of 
characteristic shape of P. jiroveci with special staining such 
as GMs, giemsa or immunofluorescence, this microscopy 
examination is difficult and quite challenging especially 
when the fungal load is low, false negative result is often 
detected.20 Microscopy examination with GMs staining 
has the same sensitivity on BAL or induction sputa, 
Table 4.  Real time PCR positivity value against prophylactic 
therapy in HIV/AIDs patients with pneumonia in Dr. 
soetomo Hospital surabaya
n
nilai  
rt pcR 
positif
nilai 
rt pcR 
negatif
Terapi Cotrimoxazole 
profilaksis
4 3 / 75% 1 / 25%
Terapi Cotrimoxazole 
definitif
3 1 / 33.3% 2 / 66.7%
Tidak mendapatkan terapi 6 1 / 16.7% 4/ 83.3%
this specimens are specimen of choice in establishing 
microbiological diagnosis of PJP.21,22 P. jiroveci can 
colonize patient with high risk condition such as chronic 
obstructive pulmonary disease, it is important to differentiate 
P. jiroveci as a infective agent or colonizer.23 Trimethoprim-
sulfamethoxazole therapy might interfere with microscopy 
examination result because non viable microorganism 
might be not detected since the characteristic cyst shape 
is destroyed during therapy. The P. jiroveci DNA can be 
detected even after prophylactic therapy but the microscopy 
examination can be difficult to achieve.16
conclusion
The majority CD4 lymphocyte count in HIV/AIDs 
patient in Dr. soetomo Hospital is below 200 cells/ µL. 
Lower CD4 lymphocyte count is a strong risk factor of 
P. jiroveci pneumonia in HIV/AIDs patients. Real time 
PCR P. jiroveci is a valuable diagnostic method with 57% 
positivity detection for P. jiroveci on patients receiving 
prophylactic and definitive therapy. 
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